According to Bruker's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.35885. At the end of 2023 the company had a P/S ratio of 3.43.
Year | P/S ratio | Change |
---|---|---|
2023 | 3.43 | -13.64% |
2022 | 3.97 | -24.52% |
2021 | 5.26 | 26.21% |
2020 | 4.17 | 9.99% |
2019 | 3.79 | 54.14% |
2018 | 2.46 | -18.65% |
2017 | 3.02 | 43.39% |
2016 | 2.11 | -14.69% |
2015 | 2.47 | 35.21% |
2014 | 1.83 | 1.49% |
2013 | 1.80 | 27.1% |
2012 | 1.42 | 13.64% |
2011 | 1.25 | -40.67% |
2010 | 2.10 | 18.17% |
2009 | 1.78 | 197.1% |
2008 | 0.5987 | -67.87% |
2007 | 1.86 | 5.42% |
2006 | 1.77 | 26.25% |
2005 | 1.40 | 10.42% |
2004 | 1.27 | -15.55% |
2003 | 1.50 | -19.58% |
2002 | 1.87 | -80.72% |
2001 | 9.68 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Thermo Fisher Scientific TMO | 5.15 | 18.26% | ๐บ๐ธ USA |
Agilent Technologies A | 6.41 | 47.11% | ๐บ๐ธ USA |
Ametek AME | 6.44 | 47.72% | ๐บ๐ธ USA |
General Electric GE | 2.90 | -33.52% | ๐บ๐ธ USA |
Illumina ILMN | 4.89 | 12.25% | ๐บ๐ธ USA |
Waters Corporation WAT | 6.91 | 58.58% | ๐บ๐ธ USA |
Danaher DHR | 7.70 | 76.71% | ๐บ๐ธ USA |
PerkinElmer
PKI | 4.31 | -1.22% | ๐บ๐ธ USA |
Accelerate Diagnostics AXDX | 1.79 | -58.88% | ๐บ๐ธ USA |
Bio-Rad Laboratories BIO | 3.72 | -14.76% | ๐บ๐ธ USA |